Back to search
FDAFDA · Food and drugs·Recall number D-0220-2024

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

Published January 17, 2024 · Recall initiated: November 17, 2023

Summary

FDA records drug Class I recall D-0220-2024, published January 17, 2024 and initiated November 17, 2023. Recalling firm: InvaGen Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 1240 boxes; Lot: Lot #: NB301030, Exp. Date 03/31/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: powder may leak out of the pouch

What to do

Voluntary: Firm initiated · Letter

Get an email if VIGABATRIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VIGABATRIN
Manufacturer
InvaGen Pharmaceuticals, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: NB301030, Exp. Date 03/31/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53 recalled?

Yes. FDA published recall D-0220-2024 on January 17, 2024. Reported hazard: Defective Container: powder may leak out of the pouch

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VIGABATRIN.